4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

C47H59N3O3 — CID 77467833

IUPAC4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESC=C(C)C1CCC2(NC(=O)Cn3cc(-c4ccccc4)cn3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12
InChIInChI=1S/C47H59N3O3/c1-30(2)35-19-24-47(49-40(51)29-50-28-34(27-48-50)31-11-9-8-10-12-31)26-25-45(6)37(41(35)47)17-18-39-44(5)22-20-36(32-13-15-33(16-14-32)42(52)53)43(3,4)38(44)21-23-46(39,45)7/h8-16,20,27-28,35,37-39,41H,1,17-19,21-26,29H2,2-7H3,(H,49,51)(H,52,53)
InChIKeyHLSZTEQFSVCVSR-UHFFFAOYSA-N
MW714.01 g/mol
LogP10.47
Rot. Bonds7

About 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (PubChem CID 77467833) has the molecular formula C47H59N3O3 and a molecular weight of 714.01 g/mol. Its IUPAC name is 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.

Molecular Properties

Compound Name4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
PubChem CID77467833
Molecular FormulaC47H59N3O3
Molecular Weight714.01 g/mol
Exact Mass713.46
IUPAC Name4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESC=C(C)C1CCC2(NC(=O)Cn3cc(-c4ccccc4)cn3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12
InChIInChI=1S/C47H59N3O3/c1-30(2)35-19-24-47(49-40(51)29-50-28-34(27-48-50)31-11-9-8-10-12-31)26-25-45(6)37(41(35)47)17-18-39-44(5)22-20-36(32-13-15-33(16-14-32)42(52)53)43(3,4)38(44)21-23-46(39,45)7/h8-16,20,27-28,35,37-39,41H,1,17-19,21-26,29H2,2-7H3,(H,49,51)(H,52,53)
InChIKeyHLSZTEQFSVCVSR-UHFFFAOYSA-N
XLogP10.47
TPSA84.22 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms53
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500714.01
LogP ≤ 510.47
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The IUPAC name of 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (CID 77467833) is 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.
What is the SMILES notation for 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The canonical SMILES for 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is C=C(C)C1CCC2(NC(=O)Cn3cc(-c4ccccc4)cn3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12.
What is the InChIKey of 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The InChIKey is HLSZTEQFSVCVSR-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H59N3O3/c1-30(2)35-19-24-47(49-40(51)29-50-28-34(27-48-50)31-11-9-8-10-12-31)26-25-45(6)37(41(35)47)17-18-39-44(5)22-20-36(32-13-15-33(16-14-32)42(52)53)43(3,4)38(44)21-23-46(39,45)7/h8-16,20,27-28,35,37-39,41H,1,17-19,21-26,29H2,2-7H3,(H,49,51)(H,52,53).
What are the key properties of 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid has a molecular weight of 714.01 g/mol, XLogP of 10.47, 7 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5a,5b,8,8,11a-pentamethyl-3a-[[2-(4-phenylpyrazol-1-yl)acetyl]amino]-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is sourced from PubChem (CID 77467833), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).